The Cancer Letter

Inside information on cancer research and drug development

Vol.
37
No.
43
November 18, 2011Nov 18, 2011
Free
DOWNLOAD THE PDF

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

Industry Groups Lobby for Lower Standards for FDA Approval

Login

Looking for IP Login?